Services
FUNDRAISING
M&A
LICENSING
STRATEGIC CONSULTING
Transactions
Team
News
Contact
stroke
Acticor Biotech announces positive results from its ACTIMIS phase 1b/2a study in patients with Acute Ischemic Stroke (AIS)
Show more
Introductions : Acticor, 20 ME à lever
Show more
Acticor Biotech Announces the Completion of Enrollment in ACTIMIS, its Key Phase 1b/2a Safety Study
Show more